From BostInno: Will This New Robot That Helps You Take Pills Have a Better Fate Than Jibo? “Pillo, tell me about yourself,” Emanuele Musini, CEO of Boston-based robotics startup Pillo Health, orders.It’s a bright Monday afternoon, and the three of us—myself, serial entrepreneur Musini and, well, Pillo The Robot—are chatting in a meeting room at WeWork on Melcher Street. Musini and ...Will This New Robot That Helps You Take Pills Have a Better Fate Than Jibo?
From Orthodontic Products Online: uLab Aligner Treatment Planning Software Reaches Significant MilestoneuLab Systems, Redwood City, Calif, the creator of an orthodontic aligner movement planning software, announced that it has passed a significant commercial milestone with over 6,000 cases completed in just 6 months.uLab launched its pilot program with a select group of orthodontists last ...
Read MoreCelebrating Women Leaders in HealthcareCivilization Ventures and First Republic Bank’s Tech and Venture Team hosted a holiday event celebrating female founders' unique opportunities and challenges.An investor and founder panel was followed by cocktails and appetizers. The audience is a co-ed group of founders and investors.Linda AveyPrecise.ly, Co-founder and CEO; 23andMe, Co-founder Abril Estr...
Read MoreGaurav Shah, CEO of Rocket Pharmaceuticals, is a man of many talents. In his spare time, he joins his wife, Falguni Shah, on stage to perform her music in Hindi, English, and Gujarati under the stage name of Falu. Gaurav is featured on her most recent album, Falu's Bazaar, which was recently nominated for a Grammy. Falu composes her own music and lyrics in a style she calls Indie Hindi, a ...
Read MoreFrom Business Wire:Tissue engineering company Prellis Biologics launched the first ever line of pre-vascularized 3D (three-dimensional) tissue scaffolds today. The scaffolds are biocompatible and can be used by researchers to grow any cell type in 3D formats 1000x larger than 3D spheroids. For the first time, therapeutics can be tested on accurate, easily replicated, fast to set-up mo...
Read MoreFrom 3DPrint.com: BioPrinting with Alzheimer’s Stem Cells May Lead to Improved Drug Testing & Treatment Alzheimer’s studies give many of us hope, whether we have a relative or friend suffering from the dreaded disease—or simply because we are hoping that a cure will be there if we begin to experience symptoms of the most common and crushing form of dementia. As bioprinting becomes valua...
Read MoreFrom Bulletin of the Atomic ScientistsBy Ali Nouri, Shahram Seyedin-Noor (General Partner, Civilization Ventures), December 7, 2018 In 1980, the World Health Organization declared the official eradication of smallpox.This was one of modern medicine’s crowning achievements—the elimination of a virus estimated to have killed more than 300 million people in the 20th century. That’s ...
Read MoreFrom Business Wire:NEW YORK--Nov. 27, 2018-- Rocket Pharmaceuticals, Inc. (Nasdaq: RCKT) (“Rocket”), a leading U.S.-based multi-platform gene therapy company, today announces that the U.S. Food and Drug Administration (FDA) has granted Regenerative Medicine Advanced Therapy (RMAT) and Fast Track designations to RP-L102, the Company’s lentiviral vector (LVV)-based gene therap...
Read MoreFrom Cambridge Independent Science and Technology Awards 2018: Evonetix Highly CommendedThe winners of the 2018 Cambridge Independent Science and Technology Awards were unveiled at a ceremony at the Hilton City Centre Hotel hosted by editor Paul Brackley, who chaired the judging panel for the awards.HIGHLY COMMENDED, Startup of the Year Award: EvonetixEvonetix, based on Chesterford Research Par...
Read MoreA recent report by SVB highlights Civilization Ventures on page 19: Almost any way you look at it, 2018 was a record year for life science and healthcare companies. We saw new levels of venture fundraising, total investment values, acquisitions and initial public offerings.Highlights in 2018 include:US healthcare venture fundraising reaches $9.6 billion —a record.US and EU VC investment in l...
Read More